The impact of surface- and nano-crystallisation on the detected amorphous content and the dissolution behaviour of amorphous indomethacin

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 1, 2012, Pages 187-193

  Priemel, P A ^a   Grohganz, H ^b   Gordon, K C ^a   Rades, T ^a,b   Strachan, C J ^a,c  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Amorphous; Analytical technique; Dissolution; Nano crystals; Quantification; Recrystallisation

Indexed keywords

INDOMETACIN;

ARTICLE; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STORAGE; INFRARED SPECTROSCOPY; PHYSICAL CHEMISTRY; SCANNING ELECTRON MICROSCOPY; X RAY POWDER DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DRUG STABILITY; DRUG STORAGE; INDOMETHACIN; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84866027904     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.05.012     Document Type: Article

References (30)

1. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification - the correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 1995 413 420
2. Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, and S. Onoue Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications International Journal of Pharmaceutics 420 2011 1 10
3. M.B. Bindu, B. Kusum, and D. Banji Novel strategies for poorly water soluble drugs International Journal of Pharmaceutical Sciences Review and Research 4 2010 76 84
4. S.B. Murdande, M.J. Pikal, R.M. Shanker, and R.H. Bogner Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals Pharmaceutical Research 27 2010 2704 2714
5. S.B. Murdande, M.J. Pikal, R.M. Shanker, and R.H. Bogner Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis Journal of Pharmaceutical Sciences 99 2010 1254 1264
6. P. Karmwar, K. Graeser, K.C. Gordon, C.J. Strachan, and T. Rades Effect of different preparation methods on the dissolution behaviour of amorphous indomethacin European Journal of Pharmaceutics and Biopharmaceutics 80 2012 459 464
7. J.E. Patterson, M.B. James, A.H. Forster, R.W. Lancaster, J.M. Butler, and T. Rades The influence of thermal and mechanical preparative techniques on the amorphous state of four poorly soluble compounds Journal of Pharmaceutical Sciences 94 2005 1998 2012
8. P. Karmwar, K. Graeser, K.C. Gordon, C.J. Strachan, and T. Rades Investigation of properties and recrystallisation behaviour of amorphous indomethacin samples prepared by different methods International Journal of Pharmaceutics 417 2011 94 100
9. V. Andronis, and G. Zografi Crystal nucleation and growth of indomethacin polymorphs from the amorphous state Journal of Non-Crystalline Solids 271 2000 236 248
10. V. Andronis, M. Yoshioka, and G. Zografi Effects of sorbed water on the crystallization of indomethacin from the amorphous state Journal of Pharmaceutical Sciences 86 1997 346 351
11. Y. Sun, L. Zhu, K.L. Kearns, M.D. Ediger, and L.A. Yu Glasses crystallize rapidly at free surfaces by growing crystals upward Proceedings of the national academy of sciences of the United States of America 108 2011 5990 5995
12. T. Wu, and L. Yu Origin of enhanced crystal growth kinetics near T-g probed with indomethacin polymorphs Journal of Physical Chemistry B 110 2006 15694 15699
13. T. Wu, and L. Yu Surface crystallization of indomethacin below T-g Pharmaceutical Research 23 2006 2350 2355
14. A.C.F. Rumondor, and L.S. Taylor Application of partial least-squares (PLSs) modeling in quantifying drug crystallinity in amorphous solid dispersions International Journal of Pharmaceutics 398 2010 155 160
15. L.C. Grisedale, M.J. Jamieson, P.S. Belton, S.A. Barker, and D.Q.M. Craig Characterization and quantification of amorphous material in milled and spray-dried salbutamol sulfate: a comparison of thermal, spectroscopic, and water vapor sorption approaches Journal of Pharmaceutical Sciences 100 2011 3114 3129
16. J.Y. Kao, C.M. McGoverin, K.A. Graeser, T. Rades, and K.C. Gordon Measurement of amorphous indomethacin stability with NIR and Raman spectroscopy Vibrational Spectroscopy 58 2012 19 26
17. A. Heinz, M. Savolainen, T. Rades, and C.J. Strachan Quantifying ternary mixtures of different solid-state forms of indomethacin by Raman and near-infrared spectroscopy European Journal of Pharmaceutical Sciences 32 2007 182 192
18. M.A.A. O'Neill, and S. Gaisford Application and use of isothermal calorimetry in pharmaceutical development International Journal of Pharmaceutics 417 2011 83 93
19. M. Vivoda, R. Roskar, and V. Kmetec The development of a quick method for amorphicity determination by isothermal microcalorimetry Journal of Thermal Analysis and Calorimetry 105 2011 1023 1030
20. M.J. Pikal, A.L. Lukes, J.E. Lang, and K. Gaines Quantitative crystallinity determinations for B-lactam antibiotics by solution calorimetry: correlations with stability Journal of Pharmaceutical Sciences 67 1978 767 772
21. B. Shah, V.K. Kakumanu, and A.K. Bansal Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids Journal of Pharmaceutical Sciences 95 2006 1641 1665
22. V.-P. Lehto, M. Tenho, K. Vaha-Heikkila, P. Harjunen, M. Paallysaho, J. Valissaari, P. Niemela, and K. Jarvinen The comparison of seven different methods to quantify the amorphous content of spray dried lactose Powder Technology 167 2006 85 93
23. M. Savolainen, K. Kogermann, A. Heinz, J. Aaltonen, L. Peltonen, C. Strachan, and J. Yliruusi Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy European Journal of Pharmaceutics and Biopharmaceutics 71 2009 71 79
24. M. Savolainen, A. Heinz, C. Strachan, K.C. Gordon, J. Yliruusi, T. Rades, and N. Sandler Screening for differences in the amorphous state of indomethacin using multivariate visualization European Journal of Pharmaceutical Sciences 30 2007 113 123
25. L. Borka Polymorphism of indomethacin - new modifications, their melting behaviour and solubility Acta Pharmaceutica Suecica 11 1974 295 303
26. H. Yamamoto 1-Acyl-indoles. 2. A new synthesis of 1-(p-chlorobenzoyl)-5- methoxy-3-indoylacetic acid and its polymorphism Chemical & Pharmaceutical Bulletin 16 1968 17
27. N. Kaneniwa, M. Otsuka, and T. Hayashi Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol Chemical & Pharmaceutical Bulletin 33 1985 3447 3455
28. C.J. Strachan, T. Rades, and K.C. Gordon A theoretical and spectroscopic study of gamma-crystalline and amorphous indomethacin Journal of Pharmacy and Pharmacology 59 2007 261 269
29. FT-IR Spectroscopy Attenuated Total Reflectance (ATR). < http://las.perkinelmer.com/content/TechnicalInfo/TCH-FTIRATR.pdf >, 2005 (cited 01.12.11).
30. B.A. Sarsfield, M. Davidovich, S. Desikan, M. Fakes, S. Futernik, J.L. Hilden, J.S. Tan, Powder X-ray diffraction detection of crystalline phases in amorphous pharmaceuticals. < http://www.icdd.com/resources/axa/vol49/V49-47. pdf >, 2011 (cited 19.12.11).